This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suzuki, A. Articles by Caverzasio, J. Search for Related Content PubMed PubMed Citation Articles by Suzuki, A. Articles by Caverzasio, J.

Regulation of Alkaline Phosphatase Activity by p38 MAP Kinase in Response to Activation of Gi Protein-Coupled Receptors by Epinephrine in Osteoblast-Like Cells¹

Division of Bone Diseases, Department of Medicine, University Hospital of Geneva, CH-1211 Geneva 14, Switzerland

Address all correspondence and requests for reprints to: Dr. Joseph Caverzasio, Division of Bone Diseases, Department of Medicine, University Hospital of Geneva, CH-1211 Geneva 14, Switzerland. E-mail: caverzas{at}cmu.unige.ch

The signaling mechanisms responsible for the regulation of alkaline phosphatase (ALP) activity by exogenous factors in osteoblast-like cells remain poorly understood. Among various agents, epinephrine was recently found to increase ALP activity in differentiating MC3T3-E1 cells by stimulating 1 adrenergic receptors coupled to Gi proteins. In the present study, we investigated the role of both ERK2 and p38 mitogen-activated protein (MAP) kinases in mediating this response in MC3T3-E1 cells. Our results indicate that both MAP kinases are transiently stimulated by epinephrine in differentiating cells via a pertussis toxin sensitive mechanism. The role of each MAP kinase pathway in mediating the stimulation of ALP activity by epinephrine was investigated using specific inhibitors. The MEK inhibitor PD98059, blocked ERK2 activity induced by epinephrine but had no effect on the stimulation of ALP activity. In contrast, low concentrations of SB203580, a specific inhibitor of the p38 MAP kinase, completely blunted this cellular response. However, this inhibitor had no influence on the stimulation of ALP activity induced by ascorbic acid. In conclusion, the results of this study suggest distinct roles for ERK and p38 MAP kinase pathways in regulating activity of MC3T3-E1 osteoblastic cells. The ERK pathway is likely involved in the control of cell proliferation whereas the p38 MAP kinase pathway regulates ALP activity in response to activation of Gi protein-coupled receptors.

This article has been cited by other articles:

				J. Caverzasio and D. Manen Essential Role of Wnt3a-Mediated Activation of Mitogen-Activated Protein Kinase p38 for the Stimulation of Alkaline Phosphatase Activity and Matrix Mineralization in C3H10T1/2 Mesenchymal Cells Endocrinology, November 1, 2007; 148(11): 5323 - 5330. [Abstract] [Full Text] [PDF]

				P.-L. Kuo, Y.-L. Hsu, C.-H. Chang, and J.-K. Chang Osthole-Mediated Cell Differentiation through Bone Morphogenetic Protein-2/p38 and Extracellular Signal-Regulated Kinase 1/2 Pathway in Human Osteoblast Cells J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1290 - 1299. [Abstract] [Full Text] [PDF]

				Y. Hu, E. Chan, S. X. Wang, and B. Li Activation of p38 Mitogen-Activated Protein Kinase Is Required for Osteoblast Differentiation Endocrinology, May 1, 2003; 144(5): 2068 - 2074. [Abstract] [Full Text] [PDF]

				T. Shimoaka, T. Ogasawara, A. Yonamine, D. Chikazu, H. Kawano, K. Nakamura, N. Itoh, and H. Kawaguchi Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10 J. Biol. Chem., February 22, 2002; 277(9): 7493 - 7500. [Abstract] [Full Text] [PDF]

				G. Rawadi, C. Ferrer, S. Spinella-Jaegle, S. Roman-Roman, Y. Bouali, and R. Baron 1-(5-Oxohexyl)-3,7-Dimethylxanthine, a Phosphodiesterase Inhibitor, Activates MAPK Cascades and Promotes Osteoblast Differentiation by a Mechanism Independent of PKA Activation (Pentoxyfilline Promotes Osteoblast Differentiation) Endocrinology, November 1, 2001; 142(11): 4673 - 4682. [Abstract] [Full Text] [PDF]

				M. A. Karsdal, M. S. Fjording, N. T. Foged, J.-M. Delaisse, and A. Lochter Transforming Growth Factor-beta -induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway J. Biol. Chem., October 12, 2001; 276(42): 39350 - 39358. [Abstract] [Full Text] [PDF]

				E. Hay, J. Lemonnier, O. Fromigue, and P. J. Marie Bone Morphogenetic Protein-2 Promotes Osteoblast Apoptosis through a Smad-independent, Protein Kinase C-dependent Signaling Pathway J. Biol. Chem., July 27, 2001; 276(31): 29028 - 29036. [Abstract] [Full Text] [PDF]

				C. Communal, W. S. Colucci, and K. Singh p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against beta -Adrenergic Receptor-stimulated Apoptosis. EVIDENCE FOR Gi-DEPENDENT ACTIVATION J. Biol. Chem., June 16, 2000; 275(25): 19395 - 19400. [Abstract] [Full Text] [PDF]